TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis.-论文-万方医学网

作者： Liping,Zhang ^[1] ; Bingqian,Zhang ^[1] ; Muyun,Wei ^[2] ; Zhen,Xu ^[1] ; Weiya,Kong ^[1] ; Ke,Deng ^[1] ; Xinxin,Xu ^[3] ; Lin,Zhang ^[4] ; Xingbo,Ζhao ^[2] ; Lei,Yan ^[1]

作者单位： School of Medicine, Shandong University, Jinan, Shandong 250012, P.R. China. ^[1] Department of Obstetrics and Gynecology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China. ^[2] Center for Reproductive Medicine, Reproductive Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China. ^[3] Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Maternal and Child Health Care Hospital of Shandong Province, Shandong University, Jinan, Shandong 250001, P.R. China. ^[4]

主题词青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);细胞系, 肿瘤(Cell Line, Tumor);细胞运动(Cell Movement);细胞增殖(Cell Proliferation);儿童(Child);减量调节(Down-Regulation);子宫内膜肿瘤(Endometrial Neoplasms);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);中年人(Middle Aged);次要组织相容性抗原(Minor Histocompatibility Antigens);NF-κB(NF-kappa B);Nod2信号接头蛋白质(Nod2 Signaling Adaptor Protein);预后(Prognosis);阻遏蛋白质类(Repressor Proteins);信号传导(Signal Transduction);青年人(Young Adult)

DOI 10.3892/ijo.2020.5004

PMID 32319602

发布时间 2021-09-16

检索历史清除

TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis.

International journal of oncology

相似文献

International journal of oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis.

International journal of oncology

相似文献

International journal of oncology

相关期刊

检索历史清除